{
  "page": 4,
  "value": [
    {
      "path": "_news/2020-05-01-moderna-could-begin-manufacturing-unproven-coronavirus-vaccine-in-july-ceo-says.md",
      "title": "Moderna could begin manufacturing unproven coronavirus vaccine in July, CEO says",
      "excerpt": "The race to develop a vaccine is intensely competitive and investors are watching closely for signs of progress on treatments and vaccines.",
      "heat": 100,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.cnbc.com/2020/05/01/moderna-could-begin-manufacturing-unproven-coronavirus-vaccine-in-july-ceo-says.html",
      "ampWebUrl": "https://www.cnbc.com/amp/2020/05/01/moderna-could-begin-manufacturing-unproven-coronavirus-vaccine-in-july-ceo-says.html",
      "cdnAmpWebUrl": "https://www-cnbc-com.cdn.ampproject.org/c/s/www.cnbc.com/amp/2020/05/01/moderna-could-begin-manufacturing-unproven-coronavirus-vaccine-in-july-ceo-says.html",
      "publishedDateTime": "2020-05-01T05:51:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "CNBC",
        "domain": "cnbc.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/cnbc.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://image.cnbcfm.com/api/v1/image/105182155-GettyImages-874588694.jpg?v=1544476482",
          "width": 2000,
          "height": 1333,
          "title": "Moderna could begin manufacturing unproven coronavirus vaccine in July, CEO says",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-05-01-amazon-instacart-workers-plan-may-day-strike-to-protest-treatment-during-the-coronavirus-pandemic.md",
      "title": "Amazon, Instacart workers plan May Day strike to protest treatment during the coronavirus pandemic",
      "excerpt": "Workers from Amazon, Whole Foods, Target and Instacart are fed up with what they say are inadequate measures from the companies to protect them during the spread of covid.",
      "heat": 141,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.washingtonpost.com/technology/2020/05/01/amazon-instacart-workers-strike",
      "ampWebUrl": "https://www.washingtonpost.com/technology/2020/05/01/amazon-instacart-workers-strike/?outputType=amp",
      "cdnAmpWebUrl": "https://www-washingtonpost-com.cdn.ampproject.org/c/s/www.washingtonpost.com/technology/2020/05/01/amazon-instacart-workers-strike/?outputType=amp",
      "publishedDateTime": "2020-05-01T05:08:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Washington Post",
        "domain": "washingtonpost.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/washingtonpost.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://www.washingtonpost.com/resizer/cxBHhA0enchLo1EBomilPMV2LWo=/1440x0/smart/arc-anglerfish-washpost-prod-washpost.s3.amazonaws.com/public/VHKTBPTZBYI6VIYRVWYTIRYZVE.jpg",
          "width": 1440,
          "height": 895,
          "title": "Amazon, Instacart workers plan May Day strike to protest treatment during the coronavirus pandemic",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-05-01-moderna-and-lonza-announce-worldwide-strategic-collaboration-to-manufacture-modernas-vaccine-against-novel-coronavirus.md",
      "title": "Moderna and Lonza announce worldwide strategic collaboration to manufacture Moderna’s vaccine against novel coronavirus",
      "excerpt": "Under the terms of the agreement, the companies plan to establish manufacturing suites at Lonza’s facilities in the United States and Switzerland for the manufacture of mRNA-1273 at",
      "heat": null,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.pharmaceutical-business-review.com/news/moderna-and-lonza-announce-worldwide-strategic-collaboration-to-manufacture-modernas-vaccine-against-novel-coronavirus/",
      "ampWebUrl": "https://www.pharmaceutical-business-review.com/news/moderna-and-lonza-announce-worldwide-strategic-collaboration-to-manufacture-modernas-vaccine-against-novel-coronavirus/amp/",
      "cdnAmpWebUrl": "https://www-pharmaceutical--business--review-com.cdn.ampproject.org/c/s/www.pharmaceutical-business-review.com/news/moderna-and-lonza-announce-worldwide-strategic-collaboration-to-manufacture-modernas-vaccine-against-novel-coronavirus/amp/",
      "publishedDateTime": "2020-05-01T03:19:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Pharmaceutical Business Review",
        "domain": "pharmaceutical-business-review.com",
        "images": null,
        "publishers": null,
        "authors": null
      },
      "images": null,
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-05-01-moderna-and-switzerlands-lonza-strike-a-deal-on-a-potential-coronavirus-vaccine.md",
      "title": "Moderna and Switzerland's Lonza strike a deal on a potential coronavirus vaccine",
      "excerpt": "Moderna and Swiss contract drugmaker Lonza Group said on Friday they would accelerate the manufacturing of the U.S. drug developer's potential coronavirus vaccine.",
      "heat": 110,
      "tags": [
        "Switzerland",
        "CH"
      ],
      "type": "article",
      "webUrl": "https://www.cnbc.com/2020/05/01/moderna-and-switzerlands-lonza-strike-a-deal-on-a-potential-coronavirus-vaccine.html",
      "ampWebUrl": "https://www.cnbc.com/amp/2020/05/01/moderna-and-switzerlands-lonza-strike-a-deal-on-a-potential-coronavirus-vaccine.html",
      "cdnAmpWebUrl": "https://www-cnbc-com.cdn.ampproject.org/c/s/www.cnbc.com/amp/2020/05/01/moderna-and-switzerlands-lonza-strike-a-deal-on-a-potential-coronavirus-vaccine.html",
      "publishedDateTime": "2020-05-01T02:54:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "CNBC",
        "domain": "cnbc.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/cnbc.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://image.cnbcfm.com/api/v1/image/103681987-Lab_3.jpg?v=1464810904",
          "width": 4000,
          "height": 2670,
          "title": "Moderna and Switzerland's Lonza strike a deal on a potential coronavirus vaccine",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Coronavirus in Europe",
        "Coronavirus",
        "Treatment"
      ]
    },
    {
      "path": "_news/2020-05-01-us-to-speed-development-of-coronavirus-vaccine-trump.md",
      "title": "U.S. to speed development of coronavirus vaccine: Trump",
      "excerpt": "U.S. President Donald Trump said on Thursday the United States plans to accelerate the development of a coronavirus vaccine, an effort that has been dubbed \"Operation Warp Speed.\"",
      "heat": 115,
      "tags": [
        "US"
      ],
      "type": "article",
      "webUrl": "https://www.reuters.com/article/us-health-coronavirus-trump-vaccine-idUSKBN22C2YP",
      "ampWebUrl": "https://mobile.reuters.com/article/amp/idUSKBN22C2YP",
      "cdnAmpWebUrl": "https://mobile-reuters-com.cdn.ampproject.org/c/s/mobile.reuters.com/article/amp/idUSKBN22C2YP",
      "publishedDateTime": "2020-04-30T22:08:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Reuters",
        "domain": "reuters.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/reuters.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://s3.reutersmedia.net/resources/r/?m=02&d=20200430&t=2&i=1517048635&w=&fh=545px&fw=&ll=&pl=&sq=&r=LYNXMPEG3T1PO",
          "width": 824,
          "height": 545,
          "title": "U.S. to speed development of coronavirus vaccine: Trump",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Coronavirus in US",
        "Coronavirus",
        "Treatment"
      ]
    },
    {
      "path": "_news/2020-05-01-moderna-switzerlands-lonza-strike-deal-on-potential-covid-19-vaccine.md",
      "title": "Moderna, Switzerland's Lonza strike deal on potential COVID-19 vaccine",
      "excerpt": "Moderna Inc and Swiss contract drugmaker Lonza Group AG said on Friday they would accelerate the manufacturing of the U.S. drug developer's potential coronavirus vaccine.",
      "heat": 135,
      "tags": [
        "Switzerland",
        "CH"
      ],
      "type": "article",
      "webUrl": "https://www.reuters.com/article/us-health-coronavirus-moderna-lonza-grou-idUSKBN22D4GM",
      "ampWebUrl": "https://mobile.reuters.com/article/amp/idUSKBN22D4GM",
      "cdnAmpWebUrl": "https://mobile-reuters-com.cdn.ampproject.org/c/s/mobile.reuters.com/article/amp/idUSKBN22D4GM",
      "publishedDateTime": "2020-04-30T21:56:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Reuters",
        "domain": "reuters.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/reuters.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://s1.reutersmedia.net/resources/r/?m=02&d=20200501&t=2&i=1517116823&w=&fh=545px&fw=&ll=&pl=&sq=&r=LYNXMPEG402RA",
          "width": 817,
          "height": 545,
          "title": "Moderna, Switzerland's Lonza strike deal on potential COVID-19 vaccine",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Coronavirus in Europe",
        "Coronavirus",
        "Treatment"
      ]
    },
    {
      "path": "_news/2020-05-01-she-was-asked-to-pay-thousands-for-her-coronavirus-treatment-he-got-a-free-ride-shes-american-hes-italian.md",
      "title": "She was asked to pay thousands for her coronavirus treatment, he got a free ride. She's American. He's Italian",
      "excerpt": "Leah Blomberg and Marco Paolone both called an ambulance when their coronavirus symptoms worsened. Both spent time in intensive care, both were unconscious for days, and both were on a ventilator.",
      "heat": 100,
      "tags": null,
      "type": "article",
      "webUrl": "https://edition.cnn.com/2020/05/01/health/health-care-europe-us-medical-bills-coronavirus-intl/index.html",
      "ampWebUrl": "https://amp.cnn.com/cnn/2020/05/01/health/health-care-europe-us-medical-bills-coronavirus-intl/index.html",
      "cdnAmpWebUrl": "https://amp-cnn-com.cdn.ampproject.org/c/s/amp.cnn.com/cnn/2020/05/01/health/health-care-europe-us-medical-bills-coronavirus-intl/index.html",
      "publishedDateTime": "2020-04-30T21:13:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "CNN",
        "domain": "cnn.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/cnn.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://cdn.cnn.com/cnnnext/dam/assets/200424111326-paolone-blomberg-split-super-tease.jpg",
          "width": 1100,
          "height": 619,
          "title": "She was asked to pay thousands for her coronavirus treatment, he got a free ride. She's American. He's Italian",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-05-01-the-covid-19-vaccine-how-do-we-immunize-seven-billion-people.md",
      "title": "The COVID-19 vaccine: How do we immunize seven billion people?",
      "excerpt": "Hopes for a return to some kind of normalcy amidst the fog of a global pandemic rest on the development of some kind of COVID-19 vaccine. With over 100 different kinds of vaccines at various stages of development perhaps the most consistent message we are continually hearing is the mantra,",
      "heat": 115,
      "tags": null,
      "type": "article",
      "webUrl": "https://newatlas.com/health-wellbeing/covid19-coronavirus-vaccine-how-to-immunize-world-seven-billion-people/",
      "ampWebUrl": "https://newatlas.com/health-wellbeing/covid19-coronavirus-vaccine-how-to-immunize-world-seven-billion-people/?amp=true",
      "cdnAmpWebUrl": "https://newatlas-com.cdn.ampproject.org/c/s/newatlas.com/health-wellbeing/covid19-coronavirus-vaccine-how-to-immunize-world-seven-billion-people/?amp=true",
      "publishedDateTime": "2020-04-30T21:08:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "New Atlas",
        "domain": "newatlas.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/newatlas.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://assets.newatlas.com/dims4/default/f616d18/2147483647/strip/true/crop/1572x1048+130+0/resize/1200x800!/quality/90/?url=http%3A%2F%2Fnewatlas-brightspot.s3.amazonaws.com%2F62%2Fa5%2F9182113d49a8aa031c20aaccb8ab%2Fdepositphotos-360420562-l-2015.jpg",
          "width": 1200,
          "height": 800,
          "title": "The COVID-19 vaccine: How do we immunize seven billion people?",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-05-01-justice-dept-scrutinizes-white-house-connected-doctor-linked-to-disputed-coronavirus-treatment.md",
      "title": "Justice Dept. scrutinizes White House-connected doctor linked to disputed coronavirus treatment",
      "excerpt": "Federal prosecutors are examining the communications of a Long Island family doctor who appears frequently on Fox News and has been in touch with the White House to tout an anti-malarial as a treatment for the novel coronavirus,",
      "heat": 108,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.washingtonpost.com/politics/vladimir-zev-zelenko-fox-news-trump-hydroxychloroquine-jerome-corsi/2020/04/30/82622456-8af2-11ea-ac8a-fe9b8088e101_story.html",
      "ampWebUrl": "https://www.washingtonpost.com/politics/vladimir-zev-zelenko-fox-news-trump-hydroxychloroquine-jerome-corsi/2020/04/30/82622456-8af2-11ea-ac8a-fe9b8088e101_story.html?outputType=amp",
      "cdnAmpWebUrl": "https://www-washingtonpost-com.cdn.ampproject.org/c/s/www.washingtonpost.com/politics/vladimir-zev-zelenko-fox-news-trump-hydroxychloroquine-jerome-corsi/2020/04/30/82622456-8af2-11ea-ac8a-fe9b8088e101_story.html?outputType=amp",
      "publishedDateTime": "2020-04-30T21:06:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Washington Post",
        "domain": "washingtonpost.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/washingtonpost.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://www.washingtonpost.com/resizer/X1eRpiNbYn0Tfy3zHTJzG45DeLs=/1440x0/smart/arc-anglerfish-washpost-prod-washpost.s3.amazonaws.com/public/FG3XIDULHEI6VAG72JFTLJLIVY.jpg",
          "width": 1440,
          "height": 960,
          "title": "Justice Dept. scrutinizes White House-connected doctor linked to disputed coronavirus treatment",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Coronavirus",
        "Treatment"
      ]
    },
    {
      "path": "_news/2020-05-01-gilead-to-work-with-partners-to-ramp-up-production-of-potential-coronavirus-treatment.md",
      "title": "Gilead to work with partners to ramp up production of potential coronavirus treatment",
      "excerpt": "Gilead Sciences Inc, maker of the experimental coronavirus drug remdesivir, on Thursday said it will work with international partners to expand production of the potential COVID-19 treatment.",
      "heat": 113,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.reuters.com/article/us-gilead-sciences-results-idUSKBN22C3PO",
      "ampWebUrl": "https://mobile.reuters.com/article/amp/idUSKBN22C3PO",
      "cdnAmpWebUrl": "https://mobile-reuters-com.cdn.ampproject.org/c/s/mobile.reuters.com/article/amp/idUSKBN22C3PO",
      "publishedDateTime": "2020-04-30T17:29:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Reuters",
        "domain": "reuters.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/reuters.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://s3.reutersmedia.net/resources/r/?m=02&d=20200501&t=2&i=1517098598&w=&fh=545px&fw=&ll=&pl=&sq=&r=LYNXMPEG3T2CQ",
          "width": 817,
          "height": 545,
          "title": "Gilead to work with partners to ramp up production of potential coronavirus treatment",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-05-01-the-latest-obstacle-in-the-search-for-a-coronavirus-treatment-too-many-drug-trials.md",
      "title": "The latest obstacle in the search for a coronavirus treatment: Too many drug trials",
      "excerpt": "Scientists and drug companies searching for a coronavirus treatment have launched so many clinical trials that some now fear they will run out of patients to enroll, trial sites or personnel to carry out the tests.",
      "heat": 129,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.politico.com/news/2020/04/30/coronavirus-drug-treatment-trials-227508",
      "ampWebUrl": "https://www.politico.com/amp/news/2020/04/30/coronavirus-drug-treatment-trials-227508",
      "cdnAmpWebUrl": "https://www-politico-com.cdn.ampproject.org/c/s/www.politico.com/amp/news/2020/04/30/coronavirus-drug-treatment-trials-227508",
      "publishedDateTime": "2020-04-30T17:25:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Politico",
        "domain": "politico.com",
        "images": null,
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://static.politico.com/50/a5/ded3a3fc4117af9e5e549a838873/200430-coronavirus-vaccine-ap-773.jpg",
          "width": 1160,
          "height": 773,
          "title": "The latest obstacle in the search for a coronavirus treatment: Too many drug trials",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-04-30-inovio-ramps-up-production-of-its-coronavirus-vaccine-candidate.md",
      "title": "Inovio Ramps Up Production of Its Coronavirus Vaccine Candidate",
      "excerpt": "Inovio Pharmaceuticals' (NASDAQ:INO) SARS-CoV-2 vaccine candidate, INO-4800, is only in phase 1 development, but the biotech is already preparing to produce it at scale through a",
      "heat": 105,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.fool.com/investing/2020/04/30/inovio-ramps-up-production-coronavirus-vaccine.aspx?source=iedfolrf0000001",
      "ampWebUrl": "https://www.fool.com/amp/investing/2020/04/30/inovio-ramps-up-production-coronavirus-vaccine.aspx",
      "cdnAmpWebUrl": "https://www-fool-com.cdn.ampproject.org/c/s/www.fool.com/amp/investing/2020/04/30/inovio-ramps-up-production-coronavirus-vaccine.aspx",
      "publishedDateTime": "2020-04-30T16:35:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "The Motley Fool",
        "domain": "fool.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/fool.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F570713%2Fvaccination-2.jpg&w=1200&op=resize",
          "width": 1200,
          "height": 800,
          "title": "Inovio Ramps Up Production of Its Coronavirus Vaccine Candidate",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-04-30-coronavirus-postponement-of-ivf-treatment-heartbreaking.md",
      "title": "Coronavirus: Postponement of IVF treatment 'heartbreaking'",
      "excerpt": "A woman whose fertility treatment was stopped because of the coronavirus outbreak said she felt lost not knowing when she would be able to have a baby. Katy and her husband Tom, from Exeter, Devon, started IVF after going through two miscarriages,",
      "heat": 120,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.bbc.com/news/uk-england-devon-52484549",
      "ampWebUrl": "https://www.bbc.com/news/amp/uk-england-devon-52484549",
      "cdnAmpWebUrl": "https://www-bbc-com.cdn.ampproject.org/c/s/www.bbc.com/news/amp/uk-england-devon-52484549",
      "publishedDateTime": "2020-04-30T16:30:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "BBC",
        "domain": "bbc.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/bbc.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://ichef.bbci.co.uk/news/1024/cpsprodpb/E6FE/production/_112043195_f75f803f-9752-4c7a-b2cc-0c3c296bcb22.jpg",
          "width": 1024,
          "height": 576,
          "title": "Coronavirus: Postponement of IVF treatment 'heartbreaking'",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-04-30-gilead-spending-50-million-to-test-and-manufacture-coronavirus-drug-candidate-remdesivir.md",
      "title": "Gilead spending $50 million to test and manufacture coronavirus drug candidate remdesivir",
      "excerpt": "Gilead Sciences Inc. reported better-than-expected earnings for the first quarter of the year on Thursday and detailed more of its work on remdesivir,",
      "heat": 121,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.marketwatch.com/story/gilead-plans-to-spend-50-million-to-test-and-manufacture-covid-19-drug-candidate-remdesivir-2020-04-30",
      "ampWebUrl": "https://www.marketwatch.com/amp/story/guid/4B030904-8B0F-11EA-805E-BE7772630DE1",
      "cdnAmpWebUrl": "https://www-marketwatch-com.cdn.ampproject.org/c/s/www.marketwatch.com/amp/story/guid/4B030904-8B0F-11EA-805E-BE7772630DE1",
      "publishedDateTime": "2020-04-30T14:24:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "MarketWatch",
        "domain": "marketwatch.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/marketwatch.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://s.marketwatch.com/public/resources/images/MW-IF591_gilead_ZH_20200430143651.jpg",
          "width": 890,
          "height": 501,
          "title": "Gilead spending $50 million to test and manufacture coronavirus drug candidate remdesivir",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus",
        "Stock Impact"
      ]
    },
    {
      "path": "_news/2020-04-30-gilead-aims-to-expand-remdesivir-output-for-covid-19-posts-flat-first-quarter-results.md",
      "title": "Gilead Aims to Expand Remdesivir Output for COVID-19, Posts Flat First-Quarter Results",
      "excerpt": "Gilead Sciences Inc, maker of the experimental coronavirus drug remdesivir, on Thursday reported flat first-quarter earnings and said it with work with international partners to expand production of potential COVID-19 treatment.",
      "heat": null,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.nytimes.com/reuters/2020/04/30/business/30reuters-gilead-sciences-results.html",
      "ampWebUrl": null,
      "cdnAmpWebUrl": null,
      "publishedDateTime": "2020-04-30T13:37:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "New York Times",
        "domain": "nytimes.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/nytimes.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://static01.nyt.com/newsgraphics/images/icons/defaultPromoCrop.png",
          "width": 1200,
          "height": 630,
          "title": "Gilead Aims to Expand Remdesivir Output for COVID-19, Posts Flat First-Quarter Results",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-04-30-fda-moving-at-lightning-speed-on-remdesivir-drug-as-coronavirus-treatment.md",
      "title": "FDA Moving at 'Lightning Speed' on Remdesivir Drug as Coronavirus Treatment",
      "excerpt": "FDA Commissioner Stephen Hahn says the agency is moving at \"lightning speed\" on remdesivir but must look at \"the totality of data\" before issuing emergency use authorization of the drug.",
      "heat": 118,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.newsweek.com/fda-moving-lightning-speed-remdesivir-drug-coronavirus-treatment-1501216",
      "ampWebUrl": "https://www.newsweek.com/fda-moving-lightning-speed-remdesivir-drug-coronavirus-treatment-1501216?amp=1",
      "cdnAmpWebUrl": "https://www-newsweek-com.cdn.ampproject.org/c/s/www.newsweek.com/fda-moving-lightning-speed-remdesivir-drug-coronavirus-treatment-1501216?amp=1",
      "publishedDateTime": "2020-04-30T08:43:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Newsweek",
        "domain": "newsweek.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/newsweek.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://d.newsweek.com/en/full/1586161/coronavirus-gilead-remdesivir-drug.jpg",
          "width": 594,
          "height": 358,
          "title": "FDA Moving at 'Lightning Speed' on Remdesivir Drug as Coronavirus Treatment",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-04-30-heres-what-we-know-about-remdesivir-the-drug-being-tested-as-a-coronavirus-treatment.md",
      "title": "Here's what we know about remdesivir, the drug being tested as a coronavirus treatment",
      "excerpt": "An experimental antiviral drug is being tested as a possible treatment for COVID-19. Here's what we know about remdesivir.",
      "heat": 127,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.usatoday.com/story/news/health/2020/04/30/remdesivir-what-we-know-potential-coronavirus-treatment/3054644001/",
      "ampWebUrl": "https://amp.usatoday.com/amp/3054644001",
      "cdnAmpWebUrl": "https://amp-usatoday-com.cdn.ampproject.org/c/s/amp.usatoday.com/amp/3054644001",
      "publishedDateTime": "2020-04-30T08:32:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "USA Today",
        "domain": "usatoday.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/usatoday.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://www.gannett-cdn.com/presto/2020/04/06/USAT/6082ef61-2ef4-4f81-b3eb-54b32b810200-AP_Virus_Outbreak_Antiviral_Drug_1.JPG?auto=webp&crop=2999,1687,x0,y152&format=pjpg&width=1200",
          "width": 1200,
          "height": 675,
          "title": "Here's what we know about remdesivir, the drug being tested as a coronavirus treatment",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-04-30-us-fda-moving-with-lightning-speed-on-gileads-covid-19-drug-bloomberg.md",
      "title": "U.S. FDA moving with 'lightning speed' on Gilead's COVID-19 drug: Bloomberg",
      "excerpt": "The U.S. Food and Drug Administration is working at \"lightning speed\" to review data on Gilead Sciences Inc's experimental antiviral drug remdesivir in treating COVID-19 disease, the head of the agency told Bloomberg in an interview.",
      "heat": 103,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.reuters.com/article/us-health-coronavirus-remdesivir-fda-idUSKBN22C2J3",
      "ampWebUrl": "https://mobile.reuters.com/article/amp/idUSKBN22C2J3",
      "cdnAmpWebUrl": "https://mobile-reuters-com.cdn.ampproject.org/c/s/mobile.reuters.com/article/amp/idUSKBN22C2J3",
      "publishedDateTime": "2020-04-30T07:03:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Reuters",
        "domain": "reuters.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/reuters.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://s2.reutersmedia.net/resources/r/?m=02&d=20200430&t=2&i=1517031346&w=&fh=545px&fw=&ll=&pl=&sq=&r=LYNXMPEG3T1FH",
          "width": 818,
          "height": 545,
          "title": "U.S. FDA moving with 'lightning speed' on Gilead's COVID-19 drug: Bloomberg",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-04-30-past-coronavirus-research-grants-are-being-used-to-smear-anthony-fauci.md",
      "title": "Past Coronavirus Research Grants Are Being Used To Smear Anthony Fauci",
      "excerpt": "The National Institutes of Health has given millions of dollars to scientists studying coronaviruses. That funding didn't cause the COVID-19 pandemic.",
      "heat": 120,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.buzzfeednews.com/article/janelytvynenko/fauci-wuhan-funding-conspiracy",
      "ampWebUrl": "https://www.buzzfeednews.com/amphtml/janelytvynenko/fauci-wuhan-funding-conspiracy",
      "cdnAmpWebUrl": "https://www-buzzfeednews-com.cdn.ampproject.org/c/s/www.buzzfeednews.com/amphtml/janelytvynenko/fauci-wuhan-funding-conspiracy",
      "publishedDateTime": "2020-04-30T06:51:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "BuzzFeed News",
        "domain": "buzzfeednews.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/buzzfeednews.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://img.buzzfeed.com/buzzfeed-static/static/2020-04/29/23/asset/d6cd353c2f23/sub-buzz-77-1588202175-8.jpg?output-quality=auto&output-format=auto&downsize=640:*",
          "width": 625,
          "height": 415,
          "title": "Past Coronavirus Research Grants Are Being Used To Smear Anthony Fauci",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-04-30-cgarh-two-migrants-test-covid-19-positive-active-cases-four.md",
      "title": "C'garh: Two migrants test COVID-19 positive; active cases four",
      "excerpt": "With this, total four activecases are currently being treated in the COVID-19 ward ofAIIMS,\" he said. Their condition is stable and they are gettingtreatment as per the guidelines of the Indian Council ofMedical Research (ICMR).",
      "heat": 100,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.businessinsider.in/india/news/cgarh-two-migrants-test-covid-19-positive-active-cases-four/articleshow/75474580.cms",
      "ampWebUrl": "https://www.businessinsider.in/india/news/cgarh-two-migrants-test-covid-19-positive-active-cases-four/amp_articleshow/75474580.cms",
      "cdnAmpWebUrl": "https://www-businessinsider-in.cdn.ampproject.org/c/s/www.businessinsider.in/india/news/cgarh-two-migrants-test-covid-19-positive-active-cases-four/amp_articleshow/75474580.cms",
      "publishedDateTime": "2020-04-30T06:46:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Business Insider India",
        "domain": "businessinsider.in",
        "images": null,
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://www.businessinsider.in/thumb/75474579.cms?height=275&width=412",
          "width": 412,
          "height": 275,
          "title": "C'garh: Two migrants test COVID-19 positive; active cases four",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-04-30-fact-check-uv-light-injections-are-not-a-common-medical-treatment-or-a-covid-19-cure.md",
      "title": "Fact check: UV light injections are not a common medical treatment — or a COVID-19 cure",
      "excerpt": "As President Donald Trump received pushback for floating the idea that COVID-19 patients could receive treatment using ultraviolet light or injections of disinfectants, many people on social media raced to his defense with claims about the use of UV light as a medical treatment.",
      "heat": 112,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.usatoday.com/story/news/factcheck/2020/04/30/fact-check-uv-light-not-accepted-medical-treatment-infection/3047010001/",
      "ampWebUrl": "https://amp.usatoday.com/amp/3047010001",
      "cdnAmpWebUrl": "https://amp-usatoday-com.cdn.ampproject.org/c/s/amp.usatoday.com/amp/3047010001",
      "publishedDateTime": "2020-04-30T06:44:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "USA Today",
        "domain": "usatoday.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/usatoday.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://www.gannett-cdn.com/presto/2020/04/27/PMIF/c35749d0-d683-49b4-ac4b-c13a6d26daa2-Coronavirus.jpg?auto=webp&crop=2155,1213,x306,y0&format=pjpg&width=1200",
          "width": 1200,
          "height": 675,
          "title": "Fact check: UV light injections are not a common medical treatment — or a COVID-19 cure",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-04-30-one-in-seven-adults-would-avoid-coronavirus-treatment-due-to-cost-poll-finds.md",
      "title": "One in Seven Adults Would Avoid Coronavirus Treatment Due to Cost, Poll Finds",
      "excerpt": "\"Seeking care when exhibiting COVID-19 symptoms or when suspecting of having been infected by the coronavirus is a critical element in combating the outbreak,\" the Gallup report noted.",
      "heat": 117,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.newsweek.com/one-seven-adults-would-avoid-coronavirus-treatment-due-cost-poll-finds-1501211",
      "ampWebUrl": "https://www.newsweek.com/one-seven-adults-would-avoid-coronavirus-treatment-due-cost-poll-finds-1501211?amp=1",
      "cdnAmpWebUrl": "https://www-newsweek-com.cdn.ampproject.org/c/s/www.newsweek.com/one-seven-adults-would-avoid-coronavirus-treatment-due-cost-poll-finds-1501211?amp=1",
      "publishedDateTime": "2020-04-30T06:18:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Newsweek",
        "domain": "newsweek.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/newsweek.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://d.newsweek.com/en/full/1586118/new-york-hospital.jpg",
          "width": 1024,
          "height": 703,
          "title": "One in Seven Adults Would Avoid Coronavirus Treatment Due to Cost, Poll Finds",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-04-30-drug-remdesivir-shows-promise-as-possible-coronavirus-treatment.md",
      "title": "Drug remdesivir shows promise as possible coronavirus treatment",
      "excerpt": "An experimental drug is showing promise in treating the coronavirus. Preliminary results from a clinical trial carried out by the National Institutes of Health found patients taking remdesivir recovered an average of four days sooner than those on a placebo.",
      "heat": 120,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.cbsnews.com/video/drug-remdesivir-shows-promise-as-possible-coronavirus-treatment/",
      "ampWebUrl": null,
      "cdnAmpWebUrl": null,
      "publishedDateTime": "2020-04-30T05:32:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "CBS News",
        "domain": "cbsnews.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/cbsnews.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://cbsnews3.cbsistatic.com/hub/i/r/2020/04/30/345768ae-3301-40cd-9aeb-29d8c428b6fc/thumbnail/1200x630/80b79eb60cf42019f414dde7cc7cf1a6/cbsn-fusion-drug-remdesivir-shows-promise-as-possible-coronavirus-treatment-thumbnail-477543-640x360.jpg",
          "width": 1200,
          "height": 630,
          "title": "Drug remdesivir shows promise as possible coronavirus treatment",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-04-30-mallinckrodt-to-fund-trial-to-test-nitric-oxide-therapy-in-covid-19-patients.md",
      "title": "Mallinckrodt to fund trial to test nitric oxide therapy in COVID-19 patients",
      "excerpt": "Mallinckrodt Plc said on Thursday it would fund a trial conducted by medical experts, evaluating the potential benefits of its respiratory therapy, INOmax, as a treatment for lung complications in patients infected with the new coronavirus.",
      "heat": 117,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.reuters.com/article/health-coronavirus-mallinckrodt-idUSL4N2CH448",
      "ampWebUrl": "https://mobile.reuters.com/article/amp/idUSL4N2CH448",
      "cdnAmpWebUrl": "https://mobile-reuters-com.cdn.ampproject.org/c/s/mobile.reuters.com/article/amp/idUSL4N2CH448",
      "publishedDateTime": "2020-04-30T05:01:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Reuters",
        "domain": "reuters.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/reuters.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://s4.reutersmedia.net/resources_v3/images/rcom-default.png",
          "width": 1200,
          "height": 630,
          "title": "Mallinckrodt to fund trial to test nitric oxide therapy in COVID-19 patients",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-04-30-white-house-hails-possible-coronavirus-treatment-remdesivir.md",
      "title": "White House hails possible coronavirus treatment remdesivir",
      "excerpt": "A drug that may shorten the recovery time of hospitalized coronavirus patients is being hailed as a potential breakthrough in the fight against the pandemic. Dr. Anthony Fauci lauded the drug remdesivir's \"positive effect in diminishing the time to recovery\" for patients in a clinical trial.",
      "heat": 100,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.cbsnews.com/video/white-house-hails-possible-coronavirus-treatment-remdesivir/",
      "ampWebUrl": null,
      "cdnAmpWebUrl": null,
      "publishedDateTime": "2020-04-30T04:41:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "CBS News",
        "domain": "cbsnews.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/cbsnews.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://cbsnews3.cbsistatic.com/hub/i/r/2020/04/30/83411e01-25f0-48f0-81b9-8b0d6805ddee/thumbnail/1200x630/7580581aea26cfe99a1edbcc7d2710d9/cbsn-fusion-white-house-hails-possible-coronavirus-treatment-remdesivir-thumbnail-477495-640x360.jpg",
          "width": 1200,
          "height": 630,
          "title": "White House hails possible coronavirus treatment remdesivir",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-04-30-coronavirus-update-covid-19-treatment-hopes-aerospace-survival-plans.md",
      "title": "Coronavirus Update: Covid-19 Treatment Hopes, Aerospace Survival Plans",
      "excerpt": "Regulators weigh greenlighting the emergency use of a Gilead drug as Los Angeles starts offering free coronavirus tests; Boeing and Airbus plan to cut thousands of jobs; Elon Musk rails against lockdown measures.",
      "heat": 115,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.wsj.com/video/coronavirus-update-covid-19-treatment-hopes-aerospace-survival-plans/F5105BCA-A0F0-4974-BD3C-390DB86E6E9A.html",
      "ampWebUrl": null,
      "cdnAmpWebUrl": null,
      "publishedDateTime": "2020-04-30T03:54:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Wall Street Journal",
        "domain": "wsj.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/wsj.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "http://m.wsj.net/video/20200430/043020virusnews/043020virusnews_1280x720.jpg",
          "width": 1280,
          "height": 720,
          "title": "Coronavirus Update: Covid-19 Treatment Hopes, Aerospace Survival Plans",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-04-30-a-drug-can-block-this-virus-fauci-hails-covid-19-treatment-breakthrough.md",
      "title": "'A drug can block this virus': Fauci hails Covid-19 treatment breakthrough",
      "excerpt": "A vial of the drug remdesivir is visually inspected at a Gilead manufacturing site in the United States. | Gilead Sciences via AP Gilead's experimental drug remdesivir may be the first effective coronavirus treatment,",
      "heat": 118,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.politico.com/news/2020/04/29/gilead-coronavirus-remdesivir-220484",
      "ampWebUrl": "https://www.politico.com/amp/news/2020/04/29/gilead-coronavirus-remdesivir-220484",
      "cdnAmpWebUrl": "https://www-politico-com.cdn.ampproject.org/c/s/www.politico.com/amp/news/2020/04/29/gilead-coronavirus-remdesivir-220484",
      "publishedDateTime": "2020-04-30T01:49:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Politico",
        "domain": "politico.com",
        "images": null,
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://static.politico.com/10/50/4f86f43c4a1e880d24abcb47ad94/200417-drug-ap-773.jpg",
          "width": 1160,
          "height": 773,
          "title": "'A drug can block this virus': Fauci hails Covid-19 treatment breakthrough",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-04-30-european-markets-set-to-open-higher-on-coronavirus-treatment-hopes.md",
      "title": "European markets set to open higher on coronavirus treatment hopes",
      "excerpt": "European markets are set to open higher Thursday as global markets are buoyed by trials of a potentially effective coronavirus treatment.",
      "heat": 130,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.cnbc.com/2020/04/30/european-markets-coronavirus-treatment-euro-zone-data.html",
      "ampWebUrl": "https://www.cnbc.com/amp/2020/04/30/european-markets-coronavirus-treatment-euro-zone-data.html",
      "cdnAmpWebUrl": "https://www-cnbc-com.cdn.ampproject.org/c/s/www.cnbc.com/amp/2020/04/30/european-markets-coronavirus-treatment-euro-zone-data.html",
      "publishedDateTime": "2020-04-29T22:07:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "CNBC",
        "domain": "cnbc.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/cnbc.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://image.cnbcfm.com/api/v1/image/106492644-1587077419862ap_20101756277973.jpg?v=1587077569",
          "width": 2888,
          "height": 1925,
          "title": "European markets set to open higher on coronavirus treatment hopes",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus",
        "Coronavirus in Europe"
      ]
    },
    {
      "path": "_news/2020-04-30-japan-stocks-jump-more-than-2-on-hopes-of-coronavirus-treatment-chinas-manufacturing-data-misses-expectations.md",
      "title": "Japan stocks jump more than 2% on hopes of coronavirus treatment; China's manufacturing data misses expectations",
      "excerpt": "Gilead Sciences said preliminary results of a coronavirus drug trial showed at least 50% of patients treated with a five-day dosage of remdesivir improved and more than half were discharged from the hospital within two weeks.",
      "heat": 184,
      "tags": [
        "JP",
        "CN"
      ],
      "type": "article",
      "webUrl": "https://www.cnbc.com/2020/04/30/asia-markets-coronavirus-china-pmi-currencies-in-focus.html",
      "ampWebUrl": "https://www.cnbc.com/amp/2020/04/30/asia-markets-coronavirus-china-pmi-currencies-in-focus.html",
      "cdnAmpWebUrl": "https://www-cnbc-com.cdn.ampproject.org/c/s/www.cnbc.com/amp/2020/04/30/asia-markets-coronavirus-china-pmi-currencies-in-focus.html",
      "publishedDateTime": "2020-04-29T20:23:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "CNBC",
        "domain": "cnbc.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/cnbc.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://image.cnbcfm.com/api/v1/image/106450927-1584577376189gettyimages-1212912223.jpeg?v=1588203742",
          "width": 1024,
          "height": 683,
          "title": "Japan stocks jump more than 2% on hopes of coronavirus treatment; China's manufacturing data misses expectations",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Coronavirus in Japan",
        "Coronavirus in Asia",
        "Coronavirus",
        "Treatment",
        "Coronavirus in China"
      ]
    },
    {
      "path": "_news/2020-04-30-shares-jump-on-coronavirus-treatment-hopes-oil-soars.md",
      "title": "Shares jump on coronavirus treatment hopes, oil soars",
      "excerpt": "World stock markets rose sharply on Wednesday following encouraging news for an experimental COVID-19 treatment and some positive earnings reports, while beaten-up oil prices soared.",
      "heat": 120,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.reuters.com/article/us-global-markets-idUSKCN22B00K",
      "ampWebUrl": "https://mobile.reuters.com/article/amp/idUSKCN22B00K",
      "cdnAmpWebUrl": "https://mobile-reuters-com.cdn.ampproject.org/c/s/mobile.reuters.com/article/amp/idUSKCN22B00K",
      "publishedDateTime": "2020-04-29T18:22:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Reuters",
        "domain": "reuters.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/reuters.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://s2.reutersmedia.net/resources/r/?m=02&d=20200429&t=2&i=1516885802&w=&fh=545px&fw=&ll=&pl=&sq=&r=LYNXMPEG3S1I3",
          "width": 817,
          "height": 545,
          "title": "Shares jump on coronavirus treatment hopes, oil soars",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    }
  ],
  "nextPage": 5
}